Novel Quinoline Derivatives as Antitumor Agents Against HepG2 Cells: Synthesis, Characterization, In Silico, In Vitro and Docking Studies
(2020). Novel Quinoline Derivatives as Antitumor Agents Against HepG2 Cells: Synthesis, Characterization, In Silico, In Vitro and Docking Studies. EKB Journal Management System, 20(1), 23-30. doi: 10.21608/cat.2020.85762
. "Novel Quinoline Derivatives as Antitumor Agents Against HepG2 Cells: Synthesis, Characterization, In Silico, In Vitro and Docking Studies". EKB Journal Management System, 20, 1, 2020, 23-30. doi: 10.21608/cat.2020.85762
(2020). 'Novel Quinoline Derivatives as Antitumor Agents Against HepG2 Cells: Synthesis, Characterization, In Silico, In Vitro and Docking Studies', EKB Journal Management System, 20(1), pp. 23-30. doi: 10.21608/cat.2020.85762
Novel Quinoline Derivatives as Antitumor Agents Against HepG2 Cells: Synthesis, Characterization, In Silico, In Vitro and Docking Studies. EKB Journal Management System, 2020; 20(1): 23-30. doi: 10.21608/cat.2020.85762